Invitation to Presentation of Senzime’s Second Quarter 2024 Report

Rhea-AI Summary

Senzime (STO:SEZI)(OTCQX:SNZZF) has announced a webcast presentation of its second quarter 2024 report scheduled for August 26, 2024, at 11:00 CEST. The report will be published earlier the same day. CEO Philip Siberg will lead the presentation, followed by a Q&A session moderated by Erik Palin, an analyst at Carnegie Investment Bank. The event will be conducted in English and can be accessed via Senzime's investor website. Investors, analysts, and media are invited to participate, with the option to submit questions in advance to klas.palin@carnegie.se. The presentation will also be available for later viewing on Senzime's website.

News Market Reaction – SNZZF

%

1 alert

% News Effect

On the day this news was published, SNZZF declined NaN%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

UPPSALA, SWEDEN / ACCESSWIRE / August 20, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime invites investors, analysts, and media to a webcast presentation of the second quarter report for 2024 on August 26, 11:00 CEST. The report will be published during the morning of the same day.

The presentation will be held by Philip Siberg, CEO of Senzime. After the presentation, there will be a Q&A session moderated by Erik Palin, analyst at Carnegie Investment Bank. The presentation will be held in English.

Date and time: Monday, August 26, 11:00-11:30 am CEST
Place: https://www.senzime.com/investors

Questions to moderator can be emailed in advance, no later than 09:00 am CEST on Aug 26th on: klas.palin@carnegie.se

The presentation will be accessible for later viewing at Senzime's website https://www.senzime.com/investors

For further information, please contact:

Philip Siberg, CEO of Senzime AB
Phone: +46 (0) 707 90 67 34, e-mail: philip.siberg@senzime.com

Slavoljub Grujicic, CFO
Phone: +46 (0) 76 306 60 11, e-mail: slavoljub.grujicic@senzime.com

About Senzime

Senzime, headquartered in Sweden, is a leading medical device company that develops, manufactures, and markets CE- and FDA-cleared patient monitoring systems. The company provides an innovative portfolio of solutions, including the TetraGraph® and ExSpiron® 2Xi for accurate monitoring of neuromuscular and respiratory functions, typically under and after surgery. The goal is to help eliminate in-hospital complications, and radically reduce health care costs related to surgical and high acuity procedures.

Senzime targets a market opportunity valued more than SEK 40 billion per year, and operates with sales teams in the world's leading markets. The company's shares are listed on Nasdaq Stockholm Main Market (Nasdaq: SEZI) and cross-traded in the US on the OTCQX market (OTCQX: SNZZF). More information is available at senzime.com.

Attachments

Invitation to presentation of Senzime's second quarter 2024 report

SOURCE: Senzime

View the original press release on accesswire.com

FAQ

When will Senzime (SNZZF) release its Q2 2024 financial report?

Senzime will release its second quarter 2024 financial report on the morning of August 26, 2024.

Who will present Senzime's (SNZZF) Q2 2024 results?

Philip Siberg, CEO of Senzime, will present the company's Q2 2024 results.

How can investors access Senzime's (SNZZF) Q2 2024 earnings presentation?

Investors can access Senzime's Q2 2024 earnings presentation via a webcast on the company's investor website at https://www.senzime.com/investors on August 26, 2024, at 11:00 CEST.

Will there be a Q&A session during Senzime's (SNZZF) Q2 2024 earnings call?

Yes, there will be a Q&A session moderated by Erik Palin, an analyst at Carnegie Investment Bank, following the presentation.